clinical trial · NCT05716919
Multiple Ascending Dose Study of CG200745 'Ivaltinostat' Oral Capsule
Machaon Biotherapeutics, Inc.·phase1·unknown·n = 32
Hematologic MalignancySolid TumorFibrosisIvaltinostatPlacebo
brief summary
A Phase I, Double blind, Randomized, Placebo-controlled, Multiple Ascending Dose Study to evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Orally Administered 'CG-745' Capsule in Healthy Male Volunteers
started
Mar 9, 2023
primary completion
Dec 1, 2023
completion
Dec 1, 2023
last updated
Oct 23, 2023
official title
A Phase I, Double Blind, Randomized, Placebo-controlled, Multiple Ascending Dose Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Orally Administered 'Ivaltinostat' Capsule in Healthy Male Volunteers
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol